Breaking News

Cambrex Completes Pilot Plant Expansion at High Point

Begins construction of a new $24 million facility at Charles City, IA plant for the manufacture of HPAPIs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex Corp., a manufacturer of small molecule innovator and generic APIs, has completed a pilot plant expansion at its High Point, NC facility with the installation and commissioning of a fourth reactor suite, increasing the site’s reactor capacity by approximately 30%.      The new 400 sq.-ft. suite includes two 2,000 liter glass lined reactors and a 0.6 sq. m. Hastelloy C22 filter dryer, allowing the manufacture of batch sizes typically 10-100kg under cGMP conditions for clini...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters